Abiopharma

News list

Hutton Scott 🟢 acquired 97.0K shares (1 derivative) of BIODESIX INC (BDSX) at $6.46 Transaction Date: Jan 02, 2026 | Filing ID: 000066

Full text

News bot Jan. 6, 2026, 10:20 p.m.
🔍 Hutton Scott (Executive)

Company: BIODESIX INC (BDSX)

Report Date: 2026-01-02
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 97,000
Detailed Transactions and Holdings:
- Acquired 97,000 shares of Stock Options (Right to Buy) at $6.46 per share (Derivative)
  Date: 2026-01-02 | Code: A | Expires: 2036-01-01 | equity_swap_involved: 0 | shares_owned_after: 97,000.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: This option vests in a series of forty-eight successive, substantially equal monthly installments measured from January 2, 2026, generally subject to the Reporting Person's continued service through each applicable vesting date.